Related Articles
Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer
Topotecan or other agents as second‑line therapy for relapsed small‑cell lung cancer: A meta‑analysis of randomized studies
Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first‑line treatment for Japanese patients with metastatic colorectal cancer
Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non‑small‑cell lung cancer: A meta‑analysis of randomized controlled trials
Therapeutic effects and associated adverse events of multikinase inhibitors in metastatic renal cell carcinoma: A meta-analysis